1623 Capital LLC Penumbra Inc Transaction History

1623 Capital LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	BUY	$116.09 - $227.33 $55,723 - $109,118	480 Added 20.31%	2,843 $354,000
Q1 2022 May 13, 2022	SELL	$187.51 - $283.98 $22,126 - $33,509	-118 Reduced 4.76%	2,363 $525,000
Q4 2021 Feb 11, 2022	BUY	$238.08 - $288.0 $173,798 - $210,240	730 Added 41.69%	2,481 $713,000
Q2 2021 Aug 13, 2021	BUY	$235.0 - $310.7 $92,355 - $122,105	393 Added 28.94%	1,751 $480,000
Q1 2021 May 14, 2021	BUY	$175.6 - $291.43 $238,464 - $395,761	1,358 New	1,358 $367,000

372

29.1M

305K

192K

Ticker PEN
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 37,888,400
Market Cap $9.01B
Description
Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...

Get notified when there are updates to the investment portfolio of 1623 Capital LLC, based on Form 13F filings with the SEC.

Stay updated on 1623 Capital LLC with notifications on news.